Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tiotidine and cimetidine--kinetics and dynamics.

S Kaojarern, M Feldman, C T Richardson

    Clinical Pharmacology and Therapeutics
    |February 1, 1981
    PubMed
    Summary

    Tiotidine offers a longer duration of action than cimetidine due to higher plasma concentrations relative to its effective dose. This pharmacokinetic and pharmacodynamic difference explains tiotidine

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Defining hypercalciuria in nephrolithiasis.

    Kidney international·2011
    Same author

    Drug dosing in patients with impaired renal function.

    Clinical pharmacology and therapeutics·2009
    Same author

    Factors associated with exacerbation of heart failure include treatment adherence and health literacy skills.

    Clinical pharmacology and therapeutics·2009
    Same author

    Determining the effectiveness of torasemide and furosemide in heart failure: design of a randomised comparison using the regenstrief medical record system.

    Clinical drug investigation·2008
    Same author

    Diuretic therapy in congestive heart failure.

    Congestive heart failure (Greenwich, Conn.)·2002
    Same author

    Social support and health-related quality of life in chronic heart failure patients.

    Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2002

    Area of Science:

    • Pharmacology
    • Gastroenterology
    • Drug Metabolism

    Background:

    • Cimetidine is a widely used H2 receptor antagonist for managing acid-related disorders.
    • Understanding the pharmacokinetic and pharmacodynamic profiles of H2 antagonists is crucial for optimizing therapeutic efficacy.
    • Tiotidine is a newer H2 antagonist with a proposed longer duration of action compared to cimetidine.

    Purpose of the Study:

    • To compare the pharmacokinetics and pharmacodynamics of tiotidine and cimetidine.
    • To elucidate the mechanisms underlying the prolonged duration of action of tiotidine in humans.
    • To assess the relative potency and efficacy of both drugs in inhibiting gastric acid secretion.

    Main Methods:

    • Comparative pharmacokinetic analysis of oral tiotidine and cimetidine in human subjects.
    • Pharmacodynamic assessment of gastric acid secretion inhibition following drug administration.
    • Determination of plasma drug concentrations and their correlation with pharmacological effects.

    Main Results:

    • Both drugs exhibited similar absorption lag times.
    • Tiotidine absorption was slower when taken with a meal compared to fasting, and slower than cimetidine with a meal.
    • Elimination rates were similar for both drugs (2-3 hours), but oral cimetidine yielded higher plasma concentrations (AUC) than tiotidine.
    • Tiotidine was significantly more potent (1/10th the concentration) in inhibiting gastric acid secretion compared to cimetidine.
    • Recommended therapeutic doses of tiotidine resulted in higher plasma concentrations relative to effective concentrations than cimetidine.

    Conclusions:

    • Tiotidine's longer duration of effect is attributed to achieving higher plasma concentrations relative to its effective inhibitory concentration of gastric acid.
    • The enhanced potency and favorable pharmacokinetic profile of tiotidine contribute to its prolonged therapeutic efficacy.
    • These findings provide a mechanistic basis for the clinical observation of tiotidine's extended duration of action.

    Related Experiment Videos